Header Logo

Connection

Kathleen Moore to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Kathleen Moore has written about Drug Therapy, Combination.
Kathleen Moore
Connection Strength
0.041
Drug Therapy, Combination
  1. Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models. Sci Rep. 2019 12 11; 9(1):18882.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.